{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:39:03Z","timestamp":1790217543733,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.critrevonc.2026.105266","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T15:44:29Z","timestamp":1772984669000},"page":"105266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["\u201cTargeting platelets in breast cancer: Insights into pathophysiology and therapeutic strategies\u201d"],"prefix":"10.1016","volume":"223","author":[{"given":"Mohammad Reza","family":"Moghaddasnejad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najmaldin","family":"Saki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.critrevonc.2026.105266_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3892\/or.2015.4387","article-title":"Platelet-activating factor promotes motility in breast cancer cells and disrupts non-transformed breast acinar structures","volume":"35","author":"Anandi","year":"2016","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105266_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41571-018-0134-8","article-title":"A framework for the development of effective anti-metastatic agents","volume":"16","author":"Anderson","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105266_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.791272","article-title":"Transforming growth factor-beta (TGF-\u03b2) signaling in cancer-A betrayal within","volume":"13","author":"Baba","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105266_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/09537100903470298","article-title":"The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets","volume":"21","author":"Bambace","year":"2010","journal-title":"Platelets"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105266_bib5","first-page":"1359","article-title":"Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis","volume":"118","author":"Battinelli","year":"2011","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105266_bib6","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1172\/JCI200422123","article-title":"Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer","volume":"114","author":"Boucharaba","year":"2004","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105266_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/07853890410026098","article-title":"Platelet-derived VEGF, Flt-1, angiopoietin-1 and P-selectin in breast and prostate cancer: further evidence for a role of platelets in tumour angiogenesis","volume":"36","author":"Caine","year":"2004","journal-title":"Ann. Med."},{"issue":"7347","key":"10.1016\/j.critrevonc.2026.105266_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105266_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/cancers11030277","article-title":"Inhibition of NK reactivity against solid tumors by platelet-derived RANKL","volume":"11","author":"Clar","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105266_bib10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/cam4.86","article-title":"Increased platelet reactivity in patients with late-stage metastatic cancer","volume":"2","author":"Cooke","year":"2013","journal-title":"Cancer Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105266_bib11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2005.06.015","article-title":"Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets","volume":"122","author":"Denis","year":"2005","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105266_bib12","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1073\/pnas.1319269111","article-title":"TGF-\u03b2\u2013inducible microRNA-183 silences tumor-associated natural killer cells","volume":"111","author":"Donatelli","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105266_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10911-011-9217-1","article-title":"TGF-\u03b2 signaling in breast cancer cell invasion and bone metastasis","volume":"16","author":"Drabsch","year":"2011","journal-title":"J. Mammary Gland Biol. neoplasia"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105266_bib14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3233\/BD-229007","article-title":"Platelet count and breast cancer stage","volume":"41","author":"Fahdrin","year":"2023","journal-title":"Breast Dis."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105266_bib15","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/ijc.30488","article-title":"Oxidant stress as a major determinant of platelet activation in invasive breast cancer","volume":"140","author":"Ferroni","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105266_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10585-018-9874-1","article-title":"Ticagrelor inhibits platelet\u2013tumor cell interactions and metastasis in human and murine breast cancer","volume":"35","author":"Gareau","year":"2018","journal-title":"Clin. & Exp. Metastas.."},{"key":"10.1016\/j.critrevonc.2026.105266_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2019.108242","article-title":"Polyunsaturated fatty acids modulate the delivery of platelet microvesicle-derived microRNAs into human breast cancer cell lines","volume":"74","author":"Gasperi","year":"2019","journal-title":"J. Nutr. Biochem."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105266_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105266_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.thromres.2017.09.019","article-title":"Breast-cancer extracellular vesicles induce platelet activation and aggregation by tissue factor-independent and-dependent mechanisms","volume":"159","author":"Gomes","year":"2017","journal-title":"Thromb. Res."},{"key":"10.1016\/j.critrevonc.2026.105266_bib20","doi-asserted-by":"crossref","unstructured":"Graff, R.C., Haimowitz, A., Aguilan, J.T., Levine, A., Zhang, J., Yuan, W., Roose-Girma, M., Seshagiri, S., Porcelli, S.A., Gamble, M.J., 2024. Platelet PI3K\u03b2 regulates breast cancer metastasis. bioRxiv, 2024.2009. 2010.612261.","DOI":"10.1101\/2024.09.10.612261"},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105266_bib21","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.7314\/APJCP.2015.16.13.5537","article-title":"Pre-treatment elevated platelet count associates with HER2 overexpression and prognosis in patients with breast cancer","volume":"16","author":"Gu","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.critrevonc.2026.105266_bib22","article-title":"Platelet-Rich Plasma Inhibits Breast Cancer Proliferation","volume":"18","author":"Han","year":"2024","journal-title":"Clin. Med. Insight. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105266_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2026.105266_bib24","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10549-017-4463-6","article-title":"Thrombocytosis as a prognostic factor in inflammatory breast cancer","volume":"166","author":"Harano","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105266_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5603\/RPOR.a2023.0008","article-title":"High platelet count as a predicting factor of histopathological grading among invasive breast cancer individuals: a single centre experience from Indonesia","volume":"28","author":"Hermansyah","year":"2023","journal-title":"Rep. Pract. Oncol. Radiother."},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105266_bib26","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.1158\/0008-5472.CAN-08-0718","article-title":"Platelet granule secretion continuously prevents intratumor hemorrhage","volume":"68","author":"Ho-Tin-No\u00e9","year":"2008","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105266_bib27","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/cts.12070","article-title":"Initiation of aspirin therapy modulates angiogenic protein levels in women with breast cancer receiving tamoxifen therapy","volume":"6","author":"Holmes","year":"2013","journal-title":"Clin. Transl. Sci."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105266_bib28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3109\/09537104.2016.1171302","article-title":"Platelet phenotype changes associated with breast cancer and its treatment","volume":"27","author":"Holmes","year":"2016","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105266_bib29","first-page":"1227","article-title":"Angiogenesis is regulated by a novel mechanism: pro-and antiangiogenic proteins are organized into separate platelet \u03b1 granules and differentially released","volume":"111","author":"Italiano","year":"2008","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105266_bib30","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/bjc.2017.214","article-title":"Platelet releasate promotes breast cancer growth and angiogenesis via VEGF\u2013integrin cooperative signalling","volume":"117","author":"Jiang","year":"2017","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105266_bib31","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/ATVBAHA.116.308791","article-title":"Tamoxifen directly inhibits platelet angiogenic potential and platelet-mediated metastasis","volume":"37","author":"Johnson","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105266_bib32","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1158\/0008-5472.CAN-09-2123","article-title":"Platelet-derived transforming growth factor-\u03b2 down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity","volume":"69","author":"Kopp","year":"2009","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105266_bib33","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1158\/2159-8290.CD-12-0216","article-title":"Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow\u2013derived cells","volume":"2","author":"Kuznetsov","year":"2012","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105266_bib34","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2026.105266_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr3425","article-title":"Platelets, coagulation and fibrinolysis in breast cancer progression","volume":"15","author":"Lal","year":"2013","journal-title":"Breast Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105266_bib36","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105266_bib37","first-page":"3141","article-title":"Interaction of platelet-derived autotaxin with tumor integrin \u03b1V\u03b23 controls metastasis of breast cancer cells to bone","volume":"124","author":"Leblanc","year":"2014","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105266_bib38","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1021\/acs.nanolett.1c00168","article-title":"Platelet-membrane-coated nanoparticles enable vascular disrupting agent combining anti-angiogenic drug for improved tumor vessel impairment","volume":"21","author":"Li","year":"2021","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105266_bib39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/acsnano.1c06022","article-title":"Targeted inhibition of tumor inflammation and tumor-platelet crosstalk by nanoparticle-mediated drug delivery mitigates cancer metastasis","volume":"16","author":"Li","year":"2021","journal-title":"ACS nano"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105266_bib40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41568-023-00639-6","article-title":"The dynamic role of platelets in cancer progression and their therapeutic implications","volume":"24","author":"Li","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105266_bib41","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41551-017-0115-8","article-title":"Nanoparticle-mediated local depletion of tumour-associated platelets disrupts vascular barriers and augments drug accumulation in tumours","volume":"1","author":"Li","year":"2017","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.critrevonc.2026.105266_bib42","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.2147\/CMAR.S257727","article-title":"Elevated platelet count predicts poor prognosis in breast cancer patients with supraclavicular lymph node metastasis","author":"Liu","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"41","key":"10.1016\/j.critrevonc.2026.105266_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202103600","article-title":"Camouflaged Hybrid Cancer Cell-Platelet Fusion Membrane Nanovesicles Deliver Therapeutic MicroRNAs to Presensitize Triple-Negative Breast Cancer to Doxorubicin","volume":"31","author":"Liu","year":"2021","journal-title":"Adv. Funct. Mater."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105266_bib44","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3892\/ijmm.2017.2953","article-title":"Suppressive role of diallyl trisul\ufb01de in the activated platelet-mediated hematogenous metastasis of MDA-MB-231 human breast cancer cells","volume":"39","author":"Liu","year":"2017","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105266_bib45","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1073\/pnas.0406682102","article-title":"Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets","volume":"102","author":"Ma","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105266_bib46","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41573-020-0061-0","article-title":"Therapeutic strategies for thrombosis: new targets and approaches","volume":"19","author":"Mackman","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"14","key":"10.1016\/j.critrevonc.2026.105266_bib47","first-page":"1146","article-title":"Platelet glycoprotein VI promotes metastasis through interaction with cancer cell\u2013derived galectin-3","volume":"135","author":"Mammadova-Bach","year":"2020","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"04","key":"10.1016\/j.critrevonc.2026.105266_bib48","first-page":"325","article-title":"Platelets in cancer","volume":"35","author":"Mammadova-Bach","year":"2015","journal-title":"H. \u00e4Most."},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105266_bib49","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.3390\/cancers13133225","article-title":"Immune circuits to shape natural killer cells in cancer","volume":"13","author":"Mattiola","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105266_bib50","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1364827","article-title":"Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells","volume":"7","author":"Maurer","year":"2018","journal-title":"Oncoimmunology"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105266_bib51","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4252\/wjsc.v12.i11.1237","article-title":"Role of platelets and breast cancer stem cells in metastasis","volume":"12","author":"Mendoza-Almanza","year":"2020","journal-title":"World J. stem Cells"},{"issue":"525","key":"10.1016\/j.critrevonc.2026.105266_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay4860","article-title":"Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-\u03b2","volume":"12","author":"Metelli","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105266_bib53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41419-019-1367-x","article-title":"Cancer cell-derived immunoglobulin G activates platelets by binding to platelet Fc\u03b3RIIa","volume":"10","author":"Miao","year":"2019","journal-title":"Cell Death & Dis."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105266_bib54","doi-asserted-by":"crossref","first-page":"C264","DOI":"10.1152\/ajpcell.00367.2018","article-title":"The role of coagulation and platelets in colon cancer-associated thrombosis","volume":"316","author":"Mitrugno","year":"2019","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105266_bib55","first-page":"249","article-title":"A novel and essential role for Fc\u03b3RIIa in cancer cell\u2013induced platelet activation","volume":"123","author":"Mitrugno","year":"2014","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105266_bib56","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2217\/bmm-2019-0514","article-title":"The aegis: Platelets as biomarkers of tumor progression","volume":"14","author":"N Augustine","year":"2020","journal-title":"Biomark. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105266_bib57","doi-asserted-by":"crossref","first-page":"139","DOI":"10.20892\/j.issn.2095-3941.2020.0151","article-title":"VEGFR2 inhibition hampers breast cancer cell proliferation via enhanced mitochondrial biogenesis","volume":"18","author":"Ni","year":"2021","journal-title":"Cancer Biol. & Med."},{"issue":"44","key":"10.1016\/j.critrevonc.2026.105266_bib58","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/25\/44\/445101","article-title":"Anti-platelet agents augment cisplatin nanoparticle cytotoxicity by enhancing tumor vasculature permeability and drug delivery","volume":"25","author":"Pandey","year":"2014","journal-title":"Nanotechnology"},{"issue":"479","key":"10.1016\/j.critrevonc.2026.105266_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau5898","article-title":"Platelet decoys inhibit thrombosis and prevent metastatic tumor formation in preclinical models","volume":"11","author":"Papa","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105266_bib60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.thromres.2019.02.027","article-title":"Breast cancer cell-induced platelet activation is compounded by tamoxifen and anastrozole in vitro","volume":"177","author":"Pather","year":"2019","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105266_bib61","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-11-1872","article-title":"Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells","volume":"72","author":"Placke","year":"2012","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105266_bib62","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4049\/jimmunol.1103194","article-title":"GITR ligand provided by thrombopoietic cells inhibits NK cell antitumor activity","volume":"189","author":"Placke","year":"2012","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105266_bib63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI122955","article-title":"Functional significance of the platelet immune receptors GPVI and CLEC-2","volume":"129","author":"Rayes","year":"2019","journal-title":"J. Clin. Investig."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105266_bib64","doi-asserted-by":"crossref","first-page":"7492","DOI":"10.1021\/acsbiomaterials.4c01362","article-title":"Platelet Membrane-Camouflaged Copper Doped CaO2 Biomimetic Nanomedicines for Breast Cancer Combination Treatment","volume":"10","author":"Ren","year":"2024","journal-title":"ACS Biomater. Sci. & Eng."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105266_bib65","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.clbc.2013.08.006","article-title":"A randomized phase II trial investigating the effect of platelet function inhibition on circulating tumor cells in patients with metastatic breast cancer","volume":"13","author":"Roop","year":"2013","journal-title":"Clin. Breast Cancer"},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105266_bib66","doi-asserted-by":"crossref","first-page":"12221","DOI":"10.3390\/ijms232012221","article-title":"Blockade of platelet CysLT1R receptor with Zafirlukast counteracts platelet Protumoral Action and prevents breast Cancer metastasis to bone and lung","volume":"23","author":"Saier","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105266_bib67","article-title":"CXC and CC chemokines as angiogenic modulators in nonhaematological tumors","volume":"2014","author":"Santoni","year":"2014","journal-title":"BioMed. Res. Int."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105266_bib68","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ccr.2013.05.008","article-title":"Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor","volume":"24","author":"Schumacher","year":"2013","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105266_bib69","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4103\/IJPM.IJPM_817_19","article-title":"Role of platelet aggregation in metastatic breast cancer patients","volume":"63","author":"Singla","year":"2020","journal-title":"Indian J. Pathol. Microbiol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105266_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230520","article-title":"Unexpected effects of long-term treatment with acetylsalicylic acid on late phase of pulmonary metastasis in murine model of orthotopic breast cancer","volume":"15","author":"Smeda","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2026.105266_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.834472","article-title":"Direct thrombin inhibitor dabigatran compromises pulmonary endothelial integrity in a murine model of breast cancer metastasis to the lungs; the role of platelets and inflammation-associated haemostasis","volume":"13","author":"Smeda","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105266_bib72","article-title":"Pretreatment thrombocytosis as a prognostic factor in metastatic breast cancer","volume":"2013","author":"Stravodimou","year":"2013","journal-title":"Int. J. Breast Cancer"},{"key":"10.1016\/j.critrevonc.2026.105266_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.764727","article-title":"Transforming growth factor-\u03b2: an agent of change in the tumor microenvironment","volume":"9","author":"Stuelten","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105266_bib74","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA a cancer journal clinicians"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105266_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107704","article-title":"Activated platelets facilitate hematogenous metastasis of breast cancer by modulating the PDGFR-\u03b2\/COX-2 axis","volume":"26","author":"Tang","year":"2023","journal-title":"IScience"},{"key":"10.1016\/j.critrevonc.2026.105266_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109200","article-title":"The effects of an aggressive breast tumor on thrombosis after antithrombin downregulation in a hypercoagulable mouse model","volume":"244","author":"\u00dcnl\u00fc","year":"2024","journal-title":"Thromb. Res."},{"issue":"25","key":"10.1016\/j.critrevonc.2026.105266_bib77","first-page":"2696","article-title":"Inhibition of platelet GPVI induces intratumor hemorrhage and increases efficacy of chemotherapy in mice","volume":"133","author":"Volz","year":"2019","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105266_bib78","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1039\/D3BM01627G","article-title":"Platelet membrane-based biochemotactic-targeting nanoplatform combining PDT with EGFR inhibition therapy for the treatment of breast cancer","volume":"12","author":"Wan","year":"2024","journal-title":"Biomater. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105266_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-016-0011","article-title":"situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy","volume":"1","author":"Wang","year":"2017","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.critrevonc.2026.105266_bib80","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2147\/CMAR.S418574","article-title":"The progress of platelets in breast Cancer","author":"Wang","year":"2023","journal-title":"Cancer Manag. Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105266_bib81","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.celrep.2018.03.092","article-title":"Platelets promote metastasis via binding tumor CD97 leading to bidirectional signaling that coordinates transendothelial migration","volume":"23","author":"Ward","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.critrevonc.2026.105266_bib82","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0049-3848(16)30095-0","article-title":"Activated tumor cell integrin \u03b1v\u03b23 cooperates with platelets to promote extravasation and metastasis from the blood stream","volume":"140","author":"Weber","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.critrevonc.2026.105266_bib83","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.lfs.2015.11.003","article-title":"Inhibition of the interactions between metastatic human breast cancer cells and platelets by \u03b2-nitrostyrene derivatives","volume":"143","author":"Wei","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.critrevonc.2026.105266_bib84","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10585-009-9299-y","article-title":"Inhibition of metastasis in a murine 4T1 breast cancer model by liposomes preventing tumor cell-platelet interactions","volume":"27","author":"Wenzel","year":"2010","journal-title":"Clin. & Exp. Metastas.."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105266_bib85","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.1073\/pnas.95.10.5556","article-title":"Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets","volume":"95","author":"Weyrich","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105266_bib86","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1073\/pnas.1911951117","article-title":"Hsp47 promotes cancer metastasis by enhancing collagen-dependent cancer cell-platelet interaction","volume":"117","author":"Xiong","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.critrevonc.2026.105266_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.141556","article-title":"Hyaluronic acid-modified biomimetic liposomes co-loaded with doxorubicin and melatonin for targeted inhibition of breast cancer proliferation and metastasis","volume":"306","author":"Xiu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"2A","key":"10.1016\/j.critrevonc.2026.105266_bib88","first-page":"847","article-title":"Platelet factor 4 gene transfection into tumor cells inhibits angiogenesis, tumor growth and metastasis","volume":"25","author":"Yamaguchi","year":"2005","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105266_bib89","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbamcr.2015.07.008","article-title":"The role of platelets in the tumor microenvironment: from solid tumors to leukemia","volume":"1863","author":"Yan","year":"2016","journal-title":"Biochimica et Biophysica Acta (BBA)Molecular Cell Research"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105266_bib90","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/2211-5463.12759","article-title":"Delivery of platelet TPM3 mRNA into breast cancer cells via microvesicles enhances metastasis","volume":"9","author":"Yao","year":"2019","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.critrevonc.2026.105266_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2019.03.024","article-title":"Bioinspired nanoplatelets for chemo-photothermal therapy of breast cancer metastasis inhibition","volume":"206","author":"Ye","year":"2019","journal-title":"Biomaterials"},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105266_bib92","doi-asserted-by":"crossref","first-page":"11281","DOI":"10.18632\/oncotarget.3596","article-title":"FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF\/AKT signaling pathway","volume":"6","author":"Yu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105266_bib93","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cellsig.2018.04.008","article-title":"Molecular mechanisms of platelet activation and aggregation induced by breast cancer cells","volume":"48","author":"Zar\u00e0","year":"2018","journal-title":"Cell. Signal."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105266_bib94","doi-asserted-by":"crossref","first-page":"7822","DOI":"10.1096\/fj.201801936RRR","article-title":"TANK-binding kinase 1 is a mediator of platelet-induced EMT in mammary carcinoma cells","volume":"33","author":"Zhang","year":"2019","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105266_bib95","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.7150\/ijbs.89822","article-title":"PKC\u03b1 Induced the Generation of Extracellular Vesicles in Activated Platelets to Promote Breast Cancer Metastasis","volume":"20","author":"Zhao","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105266_bib96","doi-asserted-by":"crossref","first-page":"11972","DOI":"10.1073\/pnas.1901987116","article-title":"Perfluorocarbon nanoparticle-mediated platelet inhibition promotes intratumoral infiltration of T cells and boosts immunotherapy","volume":"116","author":"Zhou","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105266_bib97","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz6108","article-title":"Targeted gene silencing in vivo by platelet membrane\u2013coated metal-organic framework nanoparticles","volume":"6","author":"Zhuang","year":"2020","journal-title":"Sci. Adv."},{"issue":"46","key":"10.1016\/j.critrevonc.2026.105266_bib98","doi-asserted-by":"crossref","first-page":"53198","DOI":"10.1021\/acsami.3c11594","article-title":"Sequential rocket-mode bioactivating ticagrelor prodrug nanoplatform combining light-switchable diphtherin transgene system for breast cancer metastasis inhibition","volume":"15","author":"Zou","year":"2023","journal-title":"ACS Appl. Mater. & Interfaces"},{"key":"10.1016\/j.critrevonc.2026.105266_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-019-0464-x","article-title":"Platelets promote breast cancer cell MCF-7 metastasis by direct interaction: surface integrin \u03b12\u03b21-contacting-mediated activation of Wnt-\u03b2-catenin pathway","volume":"17","author":"Zuo","year":"2019","journal-title":"Cell Commun. Signal."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826001538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:01:35Z","timestamp":1780038095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826001538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":99,"alternative-id":["S1040842826001538"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105266","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cTargeting platelets in breast cancer: Insights into pathophysiology and therapeutic strategies\u201d","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105266"}}